Key result
ARC-HBR status linked to ~2.7-fold higher 1-year BARC 3 or 5 bleeding in ACS.
Answers are grounded in this paper and cite their sources.
ARC-HBR criteria stratify 1-year major bleeding risk in East Asian ACS-PCI patients; supports validation but leaves optimal DAPT strategies open.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shinya Suzuki (2023) conducted an editorial in Acute coronary syndrome undergoing percutaneous coronary intervention (n=800). ARC-HBR High Bleeding Risk (HBR) criteria vs. ARC-HBR Non-High Bleeding Risk (non-HBR) was evaluated on BARC 3 or 5 bleeding at 1 year. ARC-HBR criteria identified higher 1-year BARC 3 or 5 bleeding in HBR versus non-HBR East Asian ACS patients in the TICAKOREA cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: